CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,222,000 | -36.2% | 745,000 | -6.3% | 0.01% | -37.5% |
| Q4 2021 | $1,916,000 | -31.2% | 795,000 | +38.3% | 0.01% | -33.3% |
| Q3 2021 | $2,783,000 | -10.5% | 575,000 | +194.8% | 0.01% | -14.3% |
| Q3 2017 | $3,109,000 | +10.6% | 195,034 | -16.1% | 0.01% | -12.5% |
| Q2 2017 | $2,812,000 | -66.8% | 232,383 | -43.1% | 0.02% | -66.0% |
| Q1 2017 | $8,480,000 | – | 408,277 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |